Antimicrobial mechanism of resveratrol-trans-dihydrodimer produced from peroxidase-catalyzed oxidation of resveratrol

Biotechnology and Bioengineering

Volumn 112, Issue 12, 2015, Pages 2417-2428

  Mora Pale, Mauricio ^a   Bhan, Namita ^a   Masuko, Sayaka ^a   James, Paul ^b   Wood, Julia ^a   Mccallum, Scott ^c   Linhardt, Robert J ^a,c   Dordick, Jonathan S ^a,c   Koffas, Mattheos A G ^a,c  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Antimicrobial; Disrupted membrane potential; DNA gyrase inhibition; Peroxidase; Resveratrol

Indexed keywords

BACILLUS CEREUS; BACTERIA; BACTERIOLOGY; CATALYSIS; CELL PROLIFERATION; DNA; ENZYME INHIBITION; ESCHERICHIA COLI; ISOMERS; LISTERIA; MICROORGANISMS; PROTEINS;

ANTIMICROBIAL; ANTIMICROBIAL MECHANISMS; DNA GYRASES; FLOW-CYTOMETRIC ANALYSIS; GRAM-POSITIVE BACTERIUM; MEMBRANE POTENTIALS; MINIMUM INHIBITORY CONCENTRATION; PEROXIDASE;

RESVERATROL;

ABC TRANSPORTER; ANTIBIOTIC AGENT; DNA BINDING PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); PALLIDOL; PEROXIDASE; RESVERATROL; RESVERATROL TRANS DIHYDRODIMER; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA; STILBENE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL MEMBRANE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYST; CELL DIVISION; DNA CONTENT; DNA REPLICATION; DNA SYNTHESIS; DOWN REGULATION; DRUG MECHANISM; DRUG OXIDATION; DRUG SYNTHESIS; ENZYME ACTIVITY; ESCHERICHIA COLI; FLOW CYTOMETRY; HYDROGEN BOND; IC50; IN VITRO STUDY; INHIBITORY CONCENTRATION; LISTERIA MONOCYTOGENES; MEMBRANE POTENTIAL; MOLECULAR DOCKING; MOLECULAR MODEL; MOLECULAR WEIGHT; OLIGOMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; THIN LAYER CHROMATOGRAPHY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION PROFILING; GRAM POSITIVE BACTERIUM; METABOLISM; MICROBIAL SENSITIVITY TEST; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SOYBEAN;

ANTI-INFECTIVE AGENTS; DNA, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GRAM-POSITIVE BACTERIA; MEMBRANE POTENTIALS; MICROBIAL SENSITIVITY TESTS; OXIDATION-REDUCTION; PEROXIDASE; SOYBEANS; STILBENES;

EID: 84946482931     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25686     Document Type: Article

References (51)

1. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J. 2010. Call of the wild: Antibiotic resistance genes in natural environments. Nat Rev Microbiol 8(4):251-259.
2. Antoniotti S, Santhanam L, Ahuja D, Hogg MG, Dordick JS. 2004. Structural diversity of peroxidase-catalyzed oxidation products of o-methoxyphenois. Org Lett 6(12):1975-1978.
3. Baquero F. 1997. Gram-positive resistance: Challenge for the development of new antibiotics. J Antimicrob Chemoth 39:1-6.
4. Bhan N, Xu P, Koffas MAG. 2013. Pathway and protein engineering approaches to produce novel and commodity small molecules. Curr Opin Biotech 24(6):1137-1143.
5. Brino L, Urzhumtsev A, Mousli M, Bronner C, Mitschler A, Oudet P, Moras D. 2000. Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center. J Biol Chem 275(13):9468-9475.
6. Brynildsen MP, Winkler JA, Spina CS, MacDonald IC, Collins JJ. 2013. Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production. Nat Biotech 31(2):160-165.
7. Butler MS. Buss AD. 2006. Natural products - The future scaffolds for novel antibiotics? Biochem Pharmacol 71(7):919-929.
8. Clardy J, Fischbach MA, Walsh CT. 2006. New antibiotics from bacterial natural products. Nat Biotechnol 24(12):1541-1550.
9. Collin F, Karkare S, Maxwell A. 2011. Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives. Appl Microbiol Biot 92(3):479-497.
10. Cui Y, Oh YJ, Lim J, Youn M, Lee I, Pak HK, Park W, Jo W, Park S. 2012. AFM study of the differential inhibitory effects of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against Gram-positive and Gram-negative bacteria. Food Microbiol 29(1):80-87.
11. Cushnie TPT, Lamb AJ. 2011. Recent advances in understanding the antibacterial properties of flavonoids. Int J Antimicrob Ag 38(2):99-107.
12. Chemler JA, Koffas MAG. 2008. Metabolic engineering for plant natural product biosynthesis in microbes. Curr Opin Biotech 19(6):597-605.
13. Dahan-Grobgeld E, Livneh Z, Maretzek AF, Polak-Charcon S, Eichenbaum Z, Degani H. 1998. Reversible induction of ATP synthesis by DNA damage and repair in Escherichia coli. J Biol Chem 273(46):30232-30238.
14. Davidson AL, Dassa E, Chen J. 2008. Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev 72(2):317-364.
15. De Leeuw E, Graham B, Phillips GJ, ten Hagen-Jongman CM, Oudega B, Luirink J. 1999. Molecular characterization of Escherichia coli FtsE and FtsX. Mol Microbiol 31(3):983-993.
16. Dwyer DJ, Belenky PA, Yang JH, MacDonald IC, Martell JD, Takahashi N, Chan CTY, Lobritz MA, Braff D, Schwarz EG, Ye JD, Pati M, Vercruysse M, Ralifo PS, Allison KR, Khalil AS, Ting AY, Walker GC, Collins JJ. 2014. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Nat Acad Sci USA 111(20):E2100-E2109.
17. Dwyer DJ, Kohanski MA, Hayete B, Collins JJ. 2007. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol 3:15.
18. El-Elimat T, Raja HA, Faeth SH, Cech NB, Oberlies NH. 2014. Flavonolignans from Aspergillus iizukae, a Fungal endophyte of milk thistle (Silybum marianum). J Nat Prod 77(2):193-199.
19. Fischbach MA, Walsh CT. 2009. Antibiotics for emerging pathogens. Science 325(5944):1089-1093.
20. Foti JJ, Devadoss B, Winkler JA, Collins JJ, Walker GC. 2012. Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 336(6079):315-319.
21. Fowler ZL, Shah K, Panepinto JC, Jacobs A, Koffas MAG. 2011. Development of non-natural flavanones as antimicrobial agents. Plos ONE 6(10):e25681.
22. Garcia-Ruiz A, Victoria Moreno-Arribas M, Martin-Alvarez PJ, Bartolome B. 2011. Comparative study of the inhibitory effects of wine polyphenols on the growth of enological lactic acid bacteria. Int J Food Microbiol 145(2-3):426-431.
23. Godreuil S, Galimand M, Gerbaud G, Jacquet C, Courvalin P. 2003. Efflux pump lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob Agents Chemoth 47(2):704-708.
24. Gradišar H, Pristovšek P, Plaper A, Jerala R. 2006. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J Med Chem 50(2):264-271.
25. Hamad B. 2010. The antimicrobial market indicators. Nat Rev Drug Discov 9(9):676-676.
26. Hammerum AM, Heuer OE. 2009. Human health hazards from antimicrobial-resistant Escherichia coli of animal origin. Clin Infec Dis 48(7):916-921.
27. Hemaiswarya S, Kruthiventi AK, Doble M. 2008. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine. 15(8):639-652.
28. Huang KS, Wang YH, Li RL, Lin M. 2000. Five new stilbene dimers from the lianas of Gnetum hainanense. J Nat Prod 63(1):86-89.
29. Jiang X, Zhou L, Gao D, Wang Y, Wang D, Zhang Z, Chen M, Su Y, Li L, Yan H, Shi L. 2012. Expression of efflux pump gene lde in ciprofloxacin-resistant foodborne isolates of Listeria monocytogenes. Microbiol Immunol 56(12):843-846.
30. Kaim G. Dimroth P. 1998. Voltage-generated torque drives the motor of the ATP synthase. EMBO J 17(20):5887-5895.
31. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130(5):797-810.
32. Ladiwala ARA, Mora-Pale M, Lin JC, Bale SS, Fishman ZS, Dordick JS, Tessier PM. 2011. Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid beta. Chembiochem. 12(11):1749-1758.
33. Lee HH, Molla MN, Cantor CR, Collins JJ. 2010. Bacterial charity work leads to population-wide resistance. Nature 467(7311):82-85.
34. Lewis K, Ausubel FM. 2006. Prospects for plant-derived antibacterials. Nat Biotechnol 24(12):1504-1507.
35. Li C, Lu J, Xu X, Hu R, Pan Y. 2012. PH -switched HRP-catalyzed dimerization of resveratrol: A selective biomimetic synthesis. Green Chem 14(12):3281-3284.
36. Lunde CS, Hartouni SR, Janc JW, Mammen M, Humphrey PP, Benton BM. 2009. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob Agents Chemoth 53(8):3375-3383.
37. Mora-Pale M, Kwon SJ, Linhardt RJ, Dordick JS. 2012. Trimer hydroxylated quinone derived from apocynin targets cysteine residues of p47(phox) preventing the activation of human vascular NADPH oxidase. Free Radical Biol Med 52(5):962-969.
38. Mora-Pale M, Weiwer M, Yu J, Linhardt RJ, Dordick JS. 2009. Inhibition of human vascular NADPH oxidase by apocynin derived oligophenols. Bioorg Med Chem 17(14):5146-5152.
39. Paulo L, Ferreira S, Gallardo E, Queiroz JA, Domingues F. 2010. Antimicrobial activity and effects of resveratrol on human pathogenic bacteria. World J Microbiol Biotechnol 26(8):1533-1538.
40. Plaper A, Golob M, Hafner I, Oblak M, Solmajer T, Jerala R. 2003. Characterization of quercetin binding site on DNA gyrase. Biochem Biophys Res Commun 306(2):530-536.
41. Saleem M, Nazir M, Ali MS, Hussain H, Lee YS, Riaz N, Jabbar A. 2010. Antimicrobial natural products: An update on future antibiotic drug candidates. Nat Prod Rep 27(2):238-254.
42. Sangwan PL, Koul JL, Koul S, Reddy MV, Thota N, Khan IA, Kumar A, Kalia NP, Qazi GN. 2008. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors. Bioorg Med Chem 16(22):9847-9857.
43. Schindler BD, Jacinto P, Kaatz GW. 2013. Inhibition of drug efflux pumps in Staphylococcus aureus: Current status of potentiating existing antibiotics. Future Microbiol 8(4):491-507.
44. Silva F, Lourenço O, Pina-Vaz C, Rodrigues A, Queiroz J, Domingues F. 2010. The use of DRAQ5 to monitor intracellular DNA in Escherichia coli by flow cytometry. J Fluoresc 20(4):907-914.
45. Silverman JA, Perlmutter NG, Shapiro HM. 2003. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemoth 47(8):2538-2544.
46. Snyder SA, Gollner A, Chiriac MI. 2011. Regioselective reactions for programmable resveratrol oligomer synthesis. Nature 474:461-466.
47. Strahl H, Hamoen LW. 2010. Membrane potential is important for bacterial cell division. Proc Nat Acad Sci USA 107(27):12281-12286.
48. Tanaka Y, Hipolito CJ, Maturana AD, Ito K, Kuroda T, Higuchi T, Katoh T, Kato HE, Hattori M, Kumazaki K, Tsukazaki T, Ishitani R, Suga H, Nureki O. 2013. Structural basis for the drug extrusion mechanism by a MATE multidrug transporter. Nature 496(7444):247-251.
49. Ultee A, Bennik MHJ, Moezelaar R. 2002. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl Environ Microbiol 68(4):1561-1568.
50. Xu P, Bhan N, Koffas MA. 2013. Engineering plant metabolism into microbes: From systems biology to synthetic biology. Curr Opin Biotechnol 24(2):291-299.
51. Zechini B, Versace I. 2009. Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat on Antiinfect Drug Discov 4(1):37-50.